Johnson & Johnson's COVID-19 vaccine could soon join
fight against pandemic
The FDA is reviewing the Johnson & Johnson COVID-19 vaccine and it could get emergency authorization by the end of the week. Unlike the Moderna and Pfizer vaccines, this one only requires only one shot. Josh Michaud, associate director for global health policy at the Kaiser Family Foundation, joined “CBSN AM” to discuss the significance.
